Home › Funds › Vontobel Holding Ltd. › ABT

Vontobel Holding Ltd. position in ABT

ABBOTT LABORATORIES · Health Care

Vontobel Holding Ltd. reported holding 884,233 shares of ABT (ABBOTT LABORATORIES) in its Q2 2026 13F filing — a position valued at US$80.2M, representing 0.49% of its reported portfolio and ranking #50 among its reported holdings. Vontobel Holding Ltd. first reported this position in Q2 2026.

Latest position (Q2 2026)884.23K sh
Reported value held$80.24M
Portfolio Weight0.49%
First reportedQ2 2026
Last changeNew

How Vontobel Holding Ltd.'s ABT position evolved

Vontobel Holding Ltd. first disclosed a stake in ABT in Q2 2026 at 884,233 shares (US$80.2M).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 884.23K $80.24M New

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 215 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), BlackRock Inc (US$13.84B), VANGUARD CAPITAL MANAGEMENT LLC (US$10.32B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →